Antimutagenic and Cytotoxicity Effects of Extracts of Eleutherococcus senticosus Maxim fruits

가시오갈피 열매 추출물의 항돌연변이원성 및 세포독성 효과

  • 전윤영 (강원대학교 바이오산업공학부) ;
  • 최승필 (강원대학교 바이오산업공학부) ;
  • 이효진 (강원대학교 바이오산업공학부) ;
  • 문선영 (강원대학교 바이오산업공학부) ;
  • 이득식 (동해대학교 외식산업학과) ;
  • 함승시 (강원대학교 바이오산업공학부)
  • Published : 2003.09.01

Abstract

This study was earned out to investigate the antimutagenic and cytotoxic effects of Eleutherococcus senticosus Maxim fruits ethanol extract on Salmonella typhimurium TA98, TA100 and cancer cell lines using Ames test and SRB assay, respectively. They were extracted with ethanol and then fractionated with hexane, chloroform, ethyl acetate, butanol and water to get active fractions. In the Ames test, most of the extracts had strong antimutagenic effects against the mutagenesis induced by MNNG, 4NQO, B(${\alpha}$)P and Trp-P-l. The ethanol extract (200 $\mu\textrm{g}$/plate) of Eleutherococcus senticosus fruits showed 87.2% inhibitory effect on the mutagenesis induced by MNNG against TA100. And also, The suppression ratio against B(${\alpha}$)P and Trp-P-l in the TA100 showed 96.1% and 95.5%, respectively. In the cytotoxic effects against human cancer cell lines (A549, AGS, MCF-7, Hep3B), the value of inhibition were mostly above 60% for each fraction (1 mg/mL). Hexane fraction (1 mg/mL) against showed the strongest cytotoxic effects of 92.7% compared to those of other fraction and butano fraetion against Hep3B was relatively high growth inhibitory effect of 82%.

가시오갈피 (Eleutherococcus senticosus Maxim) 열매의 에탄올 추출물 및 분획물의 항돌연변이원성 및 항암활성을 규명하였다. 항돌연변이원성 실험결과에서는 직접변이원인 MNNG, 4NQO 그리고 간접변이원인 B($\alpha$)p, Trp-P-1에 대해서 농도 의존적인 돌연변이 억제활성을 나타내었다. MNNG (0.4 $\mu\textrm{g}$/plate)의 격우 S. typhimurium TA100 균주에서는 시료농도 200$\mu\textrm{g}$/plate에서 클로로포름 분획물을 제외한 모든 분획물들에서 90%이상의 높은 억제효과를 나타내었다. 4NQO (0.15 $\mu\textrm{g}$/plate)에 대한 S. typhimurium TA98 균주의 경우 물 분획물의 경우 83.3%, TA100 균주에서는 에틸 아세테이트 분획물이 84.4%의 억제효과를 보였다. 간접변이원의 경우 B($\alpha$)P (10$\mu\textrm{g}$/plate)에서는 에탄을 추출물과 핵산 분획물은 시료농도 200$\mu\textrm{g}$/plate에 각각 96.1%와 97.5%로 가장 높은 억제효과를 나타내었다. 그리고 Trp-P-1 (0.15 $\mu\textrm{g}$/plate)에서는 TA100 균주의 경우 200 $\mu\textrm{g}$/plate 농도에서 에탄을 추출물과 물 분획물이 각각 95.5%차 90%로 높은 억제율을 보여주었고, TA98 균주에 대해서는 에틸아세테이트 분획물이 88.3%로 비교적 높은 억제효과를 나타내었다. 인간의 암세포인 폐암세포 (AS49), 위암세포 (AGS), 간암세포(Hep3B), 유방암세포(MCF-7)에 대한 세포독성 억제 효과를 검토한 결과 모든 암세포에서 각 분획물들은 1mg/mL 농도에서 60% 이상의 비교적 높은 암세포 성장 효과를 나타내었다. 특히 MCF-7에서 높은 암세포 성장억제 효과를 나타내었는데 핵산 분획물 (1 mg/mL)에서 92.7%의 높은 암세포 성장 억제 효과를 나타내었고 Hep3B에서는 부탄을 분획물 (1 mg/mL)에서 82%의 비교적 높은 성장억제효과를 나타내었다.

Keywords

References

  1. Doll, R. and Peto, R. (1981) The cause of cancer : Quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst., 66, 1191
  2. Colditz, G.A, Branch, L.G., Lipnick, R.J., Willett, W.C., Rosner, B., Posner, B.M.and Hennekens, C.H. (1985) Increased green and yellow vegetable intake and lowered cancer deaths in an elderly population. Am. J. Clin, Nutr., 41, 32 https://doi.org/10.1093/ajcn/41.1.32
  3. 카와키시 순로 (1996) 생체기능조절물질연구법. 송현문화사, p 39-40
  4. 許浚 (1959) 東醫寶鑑. 東方書店, 740
  5. Ovodov, Y.S, G.M. Frolova, M.Y. Nefedova and G.B. Elyakov. (1966) The glycosides of Eleutherococcus senticosus Max. I. Isolation and some properties of eleutherosides B and E. Khim. prirodn soedin, 1, 3-7
  6. Brekhmann, I.I. and Dardymov, I.D. (1969) New substances of plant origin which increase nonspecific resistance. Ann. Rev. Pharmacol., 9, 419-430 https://doi.org/10.1146/annurev.pa.09.040169.002223
  7. Ovodov, Y.S. and Shibaeva. V.I. (1969) Khim. Prirodn soedin, 5, 589
  8. Hacker, B. and Medon, P.J. (1984) Cytotoxic effects of Eleutherococcus senticosus aqueous extracts in combination with N-6-(delta 2-isopentenyl)-adenosine and l-beta-Darabinofuranosylcytosine against Ll210 leukemia cells. J. Pharm. Sci., 73, 270-272 https://doi.org/10.1002/jps.2600730235
  9. Bohn, B., Nebe, C.T. and BIrr, C. (1987) Flow Cytometric Studies with Eleutherococcus senticosus Extract as an Immunomodulating Agent. Drug Res., 37, 1193-1196
  10. Fujikawa, T., Yamaguchi, A, Morita, I., Takeda, H. and Nishibe, S. (1996) Protective effects of Acanthopanax senticosus Harms from Hokkai do and its components on gastric ulcer in restrained cold water stressed rats. Biological Pharmacy Bulletin, 19, 1227-1230 https://doi.org/10.1248/bpb.19.1227
  11. Kim, C.J, Hahn, D.R (1980) The Biological Activity of a New Glycoside, Chiisanoside from Acanthopanax chiisanensis Nakai Leaves. Yakhak Hoeji, 24, 123-134
  12. Yook, C.S., Rho, Y.S., Sed, S.H., Leem, J.Y. and Han, S.H. (1996) Chemical components of Acanthopanax divaricatus and anticancer effect in leaves. Yakhak Hoeji, 40, 251-261
  13. Ames, B.N. and Maron, D.M (1983) Revised methods for the S. typhimurium mutagenicity test. Mutaion Res., 113, 173-215 https://doi.org/10.1016/0165-1161(83)90010-9
  14. Martin, A. and Martin, C. (1997) Comparision of 5 microplate colorimetric assay for in vitro cytotoxicity testing and cell proliferation assats. Cytotechnology, 11, 49-52 https://doi.org/10.1007/BF00749057
  15. Kim, S.K. Kim, Y.G. and Han, J.S. (2000) Comparison of biological activity according to extracting solvents of four Acanthopanax root bark. Korean J. Med. Crop Sci., 8, 21-28
  16. Brekhman I.I. (1980) Eleutherococcus senticosus a new medicinal herb of the Araliaceae family. Journal of Natural products., 49, 29-31
  17. Wagner, H., Heur,Y.H. A Obermeier, Tittel, G. and Bladt, S. (1982) TLC and HPLC analysis of Eleutherococcus preparations. Planta Med., 44, 193-198 https://doi.org/10.1055/s-2007-971445
  18. Yook, C.S, Lee, D.H. and Sea, Y.K. (1976) A new forma Acanthopanax speies ( I). Kor. J. Pharmacog., 7, 179-190
  19. Hahn, D.R, Kim, C.J. and Kim, J.H. (1985) A study on chemical constituents of Acanthopanax koreanurn Nakai and its pharmaco-biological activities. Yakhak Hoeji, 29, 357-361
  20. Kim, S.K., Kim, Y.G., Lee, M.K. and Han, J.S. (2000) Comparison of biological activity according to extracting solvents of four Acanthopanax root bark. Korean Journal of Medical Crop Science, 8, 21-28
  21. Lee, W.T. (1979) Distribution of Acanthopanax plants in Korea. Kor. J. Pharmacology, 10, 103-107
  22. Shen, M.L., Zhai, S.K., Chen, H.L., Luo, Y.D., Tu, G.R. and Ou, D.W. (1991) Immuno-pharmacological effects of polysaccharides from Acanthopanax senticosus on experimental animals. International Journal of lmmunopharmacology, 13, 549-554 https://doi.org/10.1016/0192-0561(91)90075-I
  23. Hikino H., Otake, T.M. and Kono, C. (1986) Isolation and hypoglycemic activity of eleutherans A.B.C.D.E.F and G: glycans of Eleutherococcus senticosus roots. J Natural Prod., 49, 293-297 https://doi.org/10.1021/np50044a015
  24. Asano, K, Takahashi, T and Miyashita, M (1986) Effect of Eleutherococcus senticosus extract on hurnan physical working capacity. Planta Med., 37, 175-177
  25. Kupin, VI and Polevaia, E.B. (1986) Stimulation of the immunological reactivity of cancer patients by eleutherococcus extract. Vopr Onkol., 32, 21-26
  26. Yu, C.Y. Kim, S.H. Lim, J.D. Kim M.J. and Chung, I.M. (2003) Intraspecific relationship analysis by DNA markers and 'in vitro cytotoxic and antioxidant acnvity in Eleutherococcus senticosus. Toxicology in Vitro, 17, 229-236 https://doi.org/10.1016/S0887-2333(03)00008-0
  27. Kim, S.K. Kim, Y.G. and Han, J.S. (2000) Comparison of biological activity according to extracting solvents of four Acanthopanax root bark. Korean J. Med. Crop Sci., 8(1), 21-28
  28. Fang, J.N. Proksch, A and Wagner, H. (1985) Immunologically active polysaccharides of acanthopanax senticosus. Phytochemistry, 24, 2619-2622 https://doi.org/10.1016/S0031-9422(00)80681-0
  29. Davydov, M and Krikorian, A.D. (2000) Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look. Journal of Ethnopharmacology, 72, 345-393 https://doi.org/10.1016/S0378-8741(00)00181-1